ATC code L01
Abdominal pain
Abemaciclib
Aclarubicin
Active site
Adagrasib
Adenosine deaminase inhibitor
Adenosine triphosphate
Aflibercept
Aldehyde oxidase
Alitretinoin
Alkyl sulfonate
Alkylating antineoplastic agent
Alpelisib
Altretamine
Alvocidib
American Society of Health-System Pharmacists
Aminolevulinic acid
Aminopterin
Amrubicin
Amsacrine
Anagrelide
Anatomical Therapeutic Chemical Classification System
Anthracycline
Anthraquinone
Antifolate
Antimetabolite
Antineoplastic
Arsenic trioxide
Asparaginase
Asparagine
Atrasentan
Axicabtagene ciloleucel
Azacitidine
Aziridine
B-cell chronic lymphocytic leukemia
B-cell receptor
B cell
Belinostat
Belotecan
Belzutifan
Bendamustine
Bexarotene
Biological half-life
Bisantrene
Bleomycin
Bone marrow
Bortezomib
Boxed warning
Brexucabtagene autoleucel
Busulfan
CAS Registry Number
CXCR4
CXCR5
CYP3A4
Cabazitaxel
Camptotheca
Camptothecin
Capecitabine
Carboplatin
Carboquone
Carfilzomib
Carmofur
Carmustine
Celecoxib
Cell-cycle nonspecific antineoplastic agents
ChEBI
ChEMBL
ChemSpider
Chemical formula
Chemotherapy
Chills
Chlorambucil
Chlormethine
Chronic lymphocytic leukemia
Ciltacabtagene autoleucel
Cisplatin
Cladribine
Clinical trial
Clofarabine
Cmax (pharmacology)
Colitis
CompTox Chemicals Dashboard
Competitive inhibition
Copanlisib
Cositecan
Cough
Crisnatol
Crosslinking of DNA
Cyclin-dependent kinase
Cyclophosphamide
Cytarabine
DNA polymerase inhibitor
DNA replication
Dacarbazine
Dactinomycin
Daunorubicin
Daunorubicin/cytarabine
Decitabine
Demecolcine
Denileukin diftitox
Deoxyribonucleotide
Diarrhea
Dicycloplatin
Dihydrofolate reductase inhibitor
Docetaxel
Doi (identifier)
Doxifluridine
Doxorubicin
DrugBank
Drug metabolism
Drug nomenclature
Drugs.com
Duvelisib
ECHA InfoCard
Efaproxiral
Eflornithine
Elesclomol
Elsamitrucin
Enasidenib
Endothelin receptor antagonist
Entinostat
Enzyme inhibitor
Epacadostat
Epirubicin
Epothilone
Eribulin
Estramustine phosphate
Etirinotecan pegol
Etoglucid
Etoposide
European Medicines Agency
Exatecan
Excretion
FDA
Farnesyltransferase inhibitor
Fatigue (medical)
Floxuridine
Fludarabine
Fluorouracil
Follicular lymphoma
Fotemustine
Fuzuloparib
Gastrointestinal perforation
Gemcitabine
Gilead Sciences
Gimatecan
Glasdegib
Halogenation
Health Canada
Hepatotoxicity
Histone deacetylase inhibitor
Hydrazine
Hydroxycarbamide
Hyperglycemia
Hypertriglyceridemia
Hypomethylating agent
IC50
IMP dehydrogenase
IUPAC nomenclature of chemistry
Idarubicin
Idecabtagene vicleucel
Idelalisib (data page)
Ifosfamide
Imetelstat
Inavolisib
Intercalation (biochemistry)
International Chemical Identifier
Irinotecan
Isocitrate dehydrogenase
Ivosidenib
Ixabepilone
Ixazomib
JSmol
KEGG
Larotaxel
Lifileucel
Lipoxygenase inhibitor
Lisocabtagene maraleucel
List of withdrawn drugs
Lomustine
Lonidamine
Losoxantrone
Lucanthone
Lurbinectedin
Lurtotecan
Lymph node
Lymphadenopathy
M phase
Mannosulfan
Masoprocol
MedlinePlus
Melphalan
Melphalan flufenamide
Menogaril
Mercaptopurine
Metabolite
Methotrexate
Methyl aminolevulinate
Microtubule
Mitobronitol
Mitoguazone
Mitomycins
Mitotane
Mitotic inhibitor
Mitoxantrone
Mitozolomide
Molar concentration
Molar mass
Nadofaragene firadenovec
Nausea
Navitoclax
Nedaplatin
Nelarabine
Neutropenia
Nimustine
Niraparib
Niraparib/abiraterone acetate
Nitrogen mustard
Nitrosourea
Obecabtagene autoleucel
Oblimersen
Olaparib
Olutasidenib
Omacetaxine mepesuccinate
Onset of action
Oprozomib
Oral administration
Ortataxel
Oxaliplatin
P110α
P110δ
PARP inhibitor
PIK3CB
PIK3CG
PMC (identifier)
PMID (identifier)
Paclitaxel
Padeliporfin
Palbociclib
Panobinostat
Pegaspargase
Pemetrexed
Pentostatin
Pharmacokinetics
Pharmacovigilance
Phases of clinical research
Phosphodiesterase inhibitor
Phosphoinositide 3-kinase
Phosphoinositide 3-kinase inhibitor
Photodynamic therapy
Photosensitizer
Pipobroman
Pirarubicin
Pixantrone
Plasma protein binding
Platinum-based antineoplastic
Plicamycin
Plitidepsin
Pneumonia
Pneumonitis
Podophyllum peltatum
Porfimer sodium
Porphyrin
Pralatrexate
Prednimustine
Pregnancy category
Prescription drug
Procarbazine
Proteasome inhibitor
Protein kinase inhibitor
PubChem
Purine analogue
Pyrimidine analogue
Rabacfosadine
Raltitrexed
Ranimustine
Rash
Receptor antagonist
Regulation of therapeutic goods
Retinoid
Retinoid X receptor
Ribociclib
Ribonucleotide reductase inhibitor
Rituximab
Romidepsin
Route of administration
Rubitecan
Rucaparib
S phase
Satraplatin
Seliciclib
Selinexor
Semustine
Sex steroid
Signal transduction
Silatecan
Simplified molecular-input line-entry system
Sitimagene ceradenovec
Small lymphocytic lymphoma
Sotorasib
Spindle poison
Splenomegaly
Standard for the Uniform Scheduling of Medicines and Poisons
Streptomyces
Streptozotocin
Tabelecleucel
Tagraxofusp
Talaporfin
Talimogene laherparepvec
Taxane
Tazemetostat
Tebentafusp
Tegafur
Tegafur/gimeracil/oteracil
Temoporfin
Temozolomide
Teniposide
Tesetaxel
Testolactone
Thiopurine
Thiotepa
Thymidylate synthase inhibitor
Tiazofurin
Tiazofurine
Tigilanol tiglate
Tioguanine
Tipifarnib
Tisagenlecleucel
Topoisomerase inhibitor
Topotecan
Trabectedin
Treosulfan
Tretinoin
Triazene
Triaziquone
Triethylenemelamine
Trofosfamide
Tumors of the hematopoietic and lymphoid tissues
Type II topoisomerase
Type I topoisomerase
UGT1A4
USD
Umbralisib
Unique Ingredient Identifier
Uramustine
Valrubicin
Veliparib
Venetoclax
Verdinexor
Verteporfin
Vinblastine
Vinca alkaloid
Vincristine
Vindesine
Vinflunine
Vinorelbine
Vorasidenib
Vorinostat
Vosaroxin
WHO Model List of Essential Medicines
Zorubicin